Why the Aroa Biosurgery (ASX:ARX) share price is lifting today

The Aroa Biosurgery Ltd (ASX: ARX) share price is up 2.6% after the company shared positive news this morning. A new product from the soft-tissue regeneration company has received US Food and Drug Administration (FDA) clearance.

At the time of writing, the Aroa Biosurgery share price is trading at $1.17 after reaching an intraday high of $1.22 this morning.

Let’s look closer at the news of Aroa Biosurgery’s newest FDA cleared product.

Myriad Morcells

The company’s new product, Myriad Morcells, works to “kick start” a wound’s healing, according to Aroa Biosurgery vice president of research and clinical development Dr Barnaby…